AdaptHealth Corp.

AHCO Healthcare Medical Devices

In the quarter to June 2026, revenue grew 12.7%, EPS fell 1,090.0%, free cash flow fell 128.6% and total debt rose 4.30%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.

6.02 0.37 −5.79%
Market cap
$871.2M
P/E
0.0×
Fwd P/E
13.2×
Dividend yield
—
F-score
4/9
Altman Z
0.91
Beneish M
−3.26
Dividend safety
n/a

AdaptHealth Corp. (AHCO) P/E ratio

Alert me on P/E ratio

AdaptHealth Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 980× (June 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 15.6× —
FY2023 0.0× —
FY2022 40.3× 84.49%
FY2021 21.8× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 4.8× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 16.0× (6.79%)
26 more quarters

Against its own ten years

Low 0.0× High 980×
Ten-year median 4.9×
Current reading's percentile 48

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AHCO